Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03812081
Other study ID # N_50_2018
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 5, 2018
Est. completion date February 7, 2019

Study information

Verified date February 2019
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Baska mask air way(BM) in comparative study with Proseal laryngeal mask airway (PLMA) regarding performance of Baska mask improves the safety and efficacy of airway management for in patients undergoing general anesthesia by mechanical ventilation confirmation of position by fiber optic view of glottis opening and success of gastric tube insertion , Airway sealing pressure, Leak fraction, insertion time and "overall insertion" success rates, and post-operative complications (airway trauma, hoarseness, sore throat and Dysphagia ).


Description:

Maintenance of a patent airway is a major responsibility for the anesthesiologists, interruption of gas exchange, even for a few minutes, can result in catastrophic outcomes such as brain damage or death.

Supraglottic airway devices are devices that ventilate patients by delivering anaesthetic gases/oxygen above the level of the vocal cord. Since the development of the laryngeal mask airway, many other supraglottic devices have been introduced in the clinical practice of airway management, trying to offer a simple and effective alternative to endotracheal tube.

However, following experience with such simple cases, clinicians soon become comfortable with more complex cases, such as cases of longer duration, cases with sicker patient reported favorable outcomes in safety profile, risk, ease of insertion, recovery of patients and cost analyses. However, there is an under reporting of complications aris¬ing during ventilation with this device and the risk factors associated with such complications in adult patients. These include Hypoxia, laryngospasm, and difficulty with insertion, suboptimal ventilation, bronchospasm, aspiration, desaturation, hy¬potension and conversion to intubation with ETT. These can be significantly serious and life threatening


Recruitment information / eligibility

Status Completed
Enrollment 74
Est. completion date February 7, 2019
Est. primary completion date February 5, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

1. Healthy adult ASA I-II patients,

2. Both genders, aged 18-45 years,

3. Body weight between 50 and 90 kg who BMI > 30 kg/m2

4. Non-urgent surgery of planned duration up to 2 hrs

Exclusion Criteria:

1. Patient refusal

2. Patients having known tendency to nausea/vomiting or pharyngeal pathology

3. Morbid obese patients with body mass index >30 kg/m2

4. Patients known to have gastro-esophageal reflux disease (GERD), hiatus hernia or previous upper gastrointestinal tract surgery

5. History of difficult intubation, measured the common predictive indices for difficult intubation (BMI, thyromental distance,Mallampati grade, inter-incisor distance, dentition and neck movement ).

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Group A : Baska Mask Airway
Size selection is based on the manufacturer's recommendation of weight-based estimate plus clinical judgment. The Baska Mask is available in four sizes: size three (30 to 50 kg), size four (50 to 70 kg), size five (70 to 100 kg),The membranous cuff of the Baska Mask appears bulkier than the equivalent inflatable cuff on cuffed laryngeal masks. The mask can easily be decreased in size during insertion by compressing the proximal, firmer part of the mask below the airway tube, between the thumb and two fingers
Group B: Proseal Laryngeal Mask Airway
Proseal LMA (size 3,4,5) was used for ventilation according of patient body weight.Size selection is based on the manufacturer's recommendation of weight-based estimate plus clinical judgment.

Locations

Country Name City State
Egypt Ahmed Abdalla Mohamed Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Airway sealing pressure in cmH2O The airway sealing pressure is the pressure at which leak starts; in cmH2O at 5 mints post placement, this leak pressure will calculate as the plateau airway pressure reach with fresh gas flow 6 l/min, and pressure adjustment valve set at 70 cmH2O, and observing of the rise of the ventilator's airway pressure.
A ''puffing'' sound was heard near the patient's mouth (release of pressure) indicating the airway seal pressure
15 Minutes
Secondary Laryngeal view grades recorded by fiberoptic bronchoscopes. fiberoptic bronchoscopes can record Laryngeal view grades 15 Minutes
Secondary Device Complications: Patients will be monitoring for the following complications: arterial oxygen desaturation, lip damage; blood staining on mask removal and laryngospasm, the incidence and severity of throat pain, dysphagia, Heart burn, Nausea and Vomiting at arrival and discharge from the recovery unit and on the first postoperative day Through study completion
See also
  Status Clinical Trial Phase
Recruiting NCT06395922 - Blockbuster LMA Versus Baska Mask in Laparoscopic Cholecystectomy N/A